Radiation Oncology

CNS Disease

Questions discussed in this category

How do you approach the treatment of de novo, brain-only metastatic HER2 positive breast cancer?

3 Answers available

Do you routinely prescribe memantine for patients who will be receiving hippocampal sparing whole brain RT if they are already on donepezil, or is donepezil alone sufficient?

1 Answer available

What would be your approach in a patient who presented with a solitary brain metastasis that resolved after chemo without local therapy?

Would you offer consolidative brain SRS, SRS + consolidative RT to the primary (e.g. lung), consolidative RT to the primary alone?

2 Answers available

Is there a dose to the lens that would be a contraindication for future cataract surgery?

1 Answer available

Is it safe to give large fraction stereotactic irradiation for brain metastases concurrently with VEGF inhibitors?

0 Answers available

Would you recommend adjuvant radiotherapy for recurrent paraganglioma with lymph node involvement treated with salvage neck dissection with no residual disease?

Would the rate of growth, number of nodes involved, size of nodes, ENE etc. affect your decision? What volume and dose would you recommend?

1 Answer available

What features or presentations would prompt you to offer radiotherapy for paraganglioma vs. continued surveillance?

Aside from symptomatic disease, is there a certain growth cutoff or other criteria that would be a trigger for treatment?

1 Answer available

Are there any circumstances in which you would recommend adjuvant chemoradiation for resected olfactory neuroblastoma?

4 Answers available

Papers discussed in this category

Int. J. Radiat. Oncol. Biol. Phys., 2011 Jun 15

Esthesioneuroblastoma: is there a need for elective neck treatment?

Cancer, 2004-12-01

Sinonasal malignancies with neuroendocrine differentiation: patterns of failure according to histologic phenotype.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018-09-20

Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Clinical Practice Guideline Update.

Related Topics in Radiation Oncology